New combo therapy tested for Tough-to-Treat sarcoma
Disease control
Recruiting now
This study is testing whether combining two drugs, ATRA and cemiplimab, can help control advanced leiomyosarcoma, a type of cancer, in patients whose disease has worsened despite standard treatments. It will enroll 16 adults to see if the combination can shrink tumors or stop the…
Phase: PHASE2 • Sponsor: Gabriel Tinoco • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC